Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2026CellsOpen Access

Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome

View Full Paper
Ask AI
Bookmark
Share

Authors

GBGabriel BurdmanFlorida International UniversityMHMarco HannaAYAdriana YndartFlorida International University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Burdman et al. (2026) studied this question.

synapsesocial.com/papers/6abdf82e66f375461851640chttps://doi.org/10.3390/cells15191768
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families1993 · 9,604 citations
  2. 2Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons2013 · 464 citations
  3. 3Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery2025 · 53 citations
  4. 4Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation2021 · 77 citations
  5. 5Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease2016 · 285 citations